Corbus Pharmaceuticals Holdings, Inc. - Common Stock (CRBP)
12.15
-4.29 (-26.09%)
NASDAQ · Last Trade: Nov 1st, 2:55 AM EDT
Detailed Quote
| Previous Close | 16.44 |
|---|---|
| Open | 12.00 |
| Bid | 12.20 |
| Ask | 12.32 |
| Day's Range | 11.59 - 12.88 |
| 52 Week Range | 4.640 - 20.77 |
| Volume | 2,900,717 |
| Market Cap | 53.75M |
| PE Ratio (TTM) | -2.563 |
| EPS (TTM) | -4.7 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 494,758 |
Chart
About Corbus Pharmaceuticals Holdings, Inc. - Common Stock (CRBP)
Corbus Pharmaceuticals Holdings Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies to treat rare and chronic inflammatory diseases. The company specializes in cannabinoid-based treatments and aims to address unmet medical needs through its research and development efforts. Corbus is dedicated to advancing its pipeline of drug candidates, leveraging its expertise in pharmaceuticals to improve patient outcomes and enhance the quality of life for those suffering from challenging health conditions. Read More
News & Press Releases
Via Benzinga · October 31, 2025
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · October 31, 2025
Via Benzinga · October 31, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · October 30, 2025
Via Benzinga · October 30, 2025
